Order Article Reprints

Reed MR, Lyle AG, De Loose A, Maddukuri L, Learned K, Beale HC, Kephart ET, Cheney A, van den Bout A, Lee MP, et al. A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma. Cells. 2021; 10(12):3400. https://doi.org/10.3390/cells10123400

Reed, Megan R., A. Geoffrey Lyle, Annick De Loose, Leena Maddukuri, Katrina Learned, Holly C. Beale, Ellen T. Kephart, Allison Cheney, Anouk van den Bout, Madison P. Lee, and et al. 2021. "A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma" Cells 10, no. 12: 3400. https://doi.org/10.3390/cells10123400

Reed, M. R., Lyle, A. G., De Loose, A., Maddukuri, L., Learned, K., Beale, H. C., Kephart, E. T., Cheney, A., van den Bout, A., Lee, M. P., Hundley, K. N., Smith, A. M., DesRochers, T. M., Vibat, C. R. T., Gokden, M., Salama, S., Wardell, C. P., Eoff, R. L., Vaske, O. M., & Rodriguez, A. (2021). A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma. Cells, 10(12), 3400. https://doi.org/10.3390/cells10123400